Hong Kong SAR

China Resources Pharmaceutical Group, Samsung BioLogics and ZTO Express all have investors clamouring to join their IPOs, as they look to raise a combined $5.2bn.

China Resources Pharmaceutical Group has tightened the price range on its IPO, putting it on track to raise up to HK$14.8bn ($1.9bn), according to a banker on the deal.

New Silkroad Culturaltainment plans to raise HK$1.5bn ($193.3m) from a proposed open offer of shares, according to a filing with the Hong Kong Stock Exchange.

Brazil’s biggest producer of processed food BRF has signed up as a cornerstone investor on Cofco Meat Holdings’ HK$2.59bn ($333.9m) IPO, according to a statement from the São Paulo-based company.

ZTO Express and Samsung BioLogics are seeing bumper responses for their jumbo IPOs in the US and South Korea respectively, as bankers expect their bookbuilds to gain even more momentum.

China Resources Pharmaceutical Group is proving a hit with global investors, as its HK$15.7bn ($2.0bn) Hong Kong IPO is heavily oversubscribed, according to a banker at one of the leads.

Credit Suisse has hired Edwin Yeung from HSBC to set up a new US and European credit electronic trading desk in Hong Kong.

Chinese automotive component supplier Xin Point Holdings is looking to go public in Hong Kong, having filed for approval with the city's stock exchange.

Keppel DC Reit Management has kicked open a rights issue worth up to S$279.5m ($201.4m), while Zhuguang Holdings Group Co has launched a HK$1.4bn ($180.4m) offering — both to fund acquisitions.

Mark Schwartz, Goldman Sachs’ chairman for Asia Pacific and vice-chairman of the firm, has decided to leave at the end of the year, bringing an end to his 27-year-long tenure at the bank.

Société Générale Corporate & Investment Banking has named Stephen Swift as its new head of global finance for Asia Pacific, replacing Sadia Ricke who is moving to the UK.

Hong Kong's Cheung Kong Property Holdings is looking to take advantage of a recent rating upgrade to ready a bond offering.